RedHill Biopharma Announces New European and Japanese Patents for Talicia®

    NEXT STORY
    Novo Nordisk: Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors
    PREV STORY
    Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update

    WALTHAM, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or ...

    author_avatar
    NASDAQ Market News

    GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates

    ATLANTA, May 03, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: BIOCARTIS Q1 2019 BUSINESS UPDATE

    author_avatar
    NASDAQ Market News